Marshall Wace’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.11M | Buy |
+3,800
| New | +$1.25M | ﹤0.01% | 2087 |
|
|
2025
Q4 | – | Sell |
-35,857
| Closed | -$11.6M | – | 3089 |
|
|
2025
Q3 | $11.6M | Buy |
+35,857
| New | +$11.2M | 0.01% | 867 |
|
|
2024
Q3 | – | Sell |
-66,000
| Closed | -$35.8M | – | 2614 |
|
|
2024
Q2 | $35.8M | Buy |
+66,000
| New | +$34.9M | 0.05% | 333 |
|
|
2024
Q1 | – | Sell |
-129,483
| Closed | -$61.1M | – | 2536 |
|
|
2023
Q4 | $61.1M | Sell |
129,483
-325,350
| -72% | -$150M | 0.1% | 197 |
|
|
2023
Q3 | $198M | Sell |
454,833
-78,262
| -15% | -$35.5M | 0.4% | 43 |
|
|
2023
Q2 | $237M | Sell |
533,095
-12,570
| -2% | -$5.8M | 0.46% | 30 |
|
|
2023
Q1 | $251M | Buy |
545,665
+179,016
| +49% | +$85.2M | 0.53% | 28 |
|
|
2022
Q4 | $188M | Buy |
+366,649
| New | +$186M | 0.42% | 39 |
|
|
2022
Q1 | – | Sell |
-486,857
| Closed | -$226M | – | 3507 |
|
|
2021
Q4 | $226M | Buy |
486,857
+425,351
| +692% | +$179M | 0.42% | 33 |
|
|
2021
Q3 | $22.9M | Sell |
61,506
-6,146
| -9% | -$2.34M | 0.1% | 231 |
|
|
2021
Q2 | $25.8M | Sell |
67,652
-123,385
| -65% | -$47.2M | 0.12% | 180 |
|
|
2021
Q1 | $68.6M | Sell |
191,037
-46,655
| -20% | -$15M | 0.31% | 59 |
|
|
2020
Q4 | $76.3M | Buy |
237,692
+62,478
| +36% | +$19.2M | 0.41% | 43 |
|
|
2020
Q3 | $47.1M | Buy |
175,214
+119,255
| +213% | +$32.1M | 0.3% | 72 |
|
|
2020
Q2 | $14.7M | Sell |
55,959
-28,312
| -34% | -$7.55M | 0.1% | 207 |
|
|
2020
Q1 | $19.1M | Sell |
84,271
-59,188
| -41% | -$16.1M | 0.19% | 119 |
|
|
2019
Q4 | $43.3M | Buy |
143,459
+93,596
| +188% | +$25.8M | 0.3% | 76 |
|
|
2019
Q3 | $12M | Buy |
49,863
+48,036
| +2,629% | +$13.2M | 0.09% | 253 |
|
|
2019
Q2 | $515K | Sell |
1,827
-41,301
| -96% | -$11.3M | ﹤0.01% | 1075 |
|
|
2019
Q1 | $12.4M | Sell |
43,128
-28,468
| -40% | -$8.23M | 0.12% | 217 |
|
|
2018
Q4 | $18.8M | Buy |
71,596
+62,393
| +678% | +$17.2M | 0.19% | 122 |
|
|
2018
Q3 | $2.52M | Sell |
9,203
-68,112
| -88% | -$17.7M | 0.02% | 616 |
|
|
2018
Q2 | $18.4M | Buy |
+77,315
| New | +$17.9M | 0.28% | 108 |
|
|
2017
Q3 | – | Sell |
-13,361
| Closed | -$2.51M | – | 361 |
|
|
2017
Q2 | $2.51M | Buy |
+13,361
| New | +$2.4M | 0.11% | 129 |
|
|
2017
Q1 | – | Sell |
-39,523
| Closed | -$5.68M | – | 430 |
|
|
2016
Q4 | $5.68M | Buy |
39,523
+23,513
| +147% | +$3.15M | 0.04% | 443 |
|
|
2016
Q3 | $2.01M | Sell |
16,010
-481
| -3% | -$62.1K | 0.01% | 596 |
|
|
2016
Q2 | $2.17M | Buy |
+16,491
| New | +$2.26M | 0.02% | 567 |
|
|
2015
Q4 | – | Sell |
-142,811
| Closed | -$20M | – | 1009 |
|
|
2015
Q3 | $20M | Sell |
142,811
-35,151
| -20% | -$5.28M | 0.25% | 104 |
|
|
2015
Q2 | $29.2M | Buy |
177,962
+74,511
| +72% | +$11.9M | 0.38% | 74 |
|
|
2015
Q1 | $16M | Buy |
+103,451
| New | +$14.7M | 0.21% | 132 |
|
|
2014
Q4 | – | Sell |
-150,648
| Closed | -$18M | – | 852 |
|
|
2014
Q3 | $18M | Buy |
150,648
+146,147
| +3,247% | +$16.8M | 0.26% | 111 |
|
|
2014
Q2 | $484K | Sell |
4,501
-55,068
| -92% | -$5.67M | 0.01% | 609 |
|
|
2014
Q1 | $5.93M | Buy |
+59,569
| New | +$5.39M | 0.11% | 221 |
|
Other funds holding ELV
VCM
VPM
Marshall Wace's ELV Position: Q1 2026 in Review
Marshall Wace opened a new position in Elevance Health (ELV) in Q1 2026: 3,800 shares worth $1.11M. The stake represents ﹤0.01% of the portfolio and ranks #2087 among its holdings. This is a return to the name: Marshall Wace previously reported a position in ELV as recently as Q3 2025.
Marshall Wace first reported a position in ELV in Q1 2014 and has held it in 33 quarters since. The position peaked at $251M in Q1 2023. 1,463 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Marshall Wace held 3,800 shares of Elevance Health worth $1.11M as of Q1 2026.
- Elevance Health was a new Marshall Wace position in Q1 2026.
- Elevance Health made up ﹤0.01% of Marshall Wace's portfolio in Q1 2026, its #2087 holding.
- Marshall Wace first reported a position in Elevance Health in Q1 2014 and has held it in 33 quarters since.
- Marshall Wace's Elevance Health position peaked at $251M in Q1 2023.
- 1,463 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.